Update finetune triplets

surgical-equipment-anaesthesia-surgical-equipment.jsonl

@@ -0,0 +1,14 @@
+{"instruction":"Review the field safety corrective action plan to ensure that it includes clear instructions for users on how to identify and respond to the device malfunction, as required by Article 89.","context":"The Field Safety Notice draft for the ALPHAMAQUET operating table describes the malfunction in the column control unit but does not provide specific steps for users to identify the affected devices or to verify if their unit is impacted. The document instructs users to contact service if the table fails to adjust, but does not include a procedure for users to check the version of the column control unit or to confirm if the device is within the scope of the corrective action. There is no guidance on how to distinguish between a transient software glitch and the specific hardware malfunction described.","response":"Field Safety Notice 34478/26 issued by BfArM on 2026-08-17 reported that a malfunction in the column control unit may prevent adjustment of the ALPHAMAQUET operating table for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(8) of Regulation (EU) 2017/745, which requires the field safety notice to clearly indicate all the actions to be taken by users and to allow the correct identification of the device or devices involved. The procedural gap is the lack of specific identification criteria and user action steps in the notice, which prevents users from accurately determining if their device is affected and how to respond to the intermittent malfunction."}
+{"instruction":"Assess the implementation of the field safety corrective action to ensure that it effectively mitigates the risk of the device malfunction and that users are provided with clear instructions for immediate response.","context":"The Field Safety Corrective Action (FSCA) plan for the ALPHAMAQUET operating table instructs customers to stop using affected devices if the cable remote or override panel fails. However, the plan does not provide a method for users to confirm that the device has been corrected or to verify that the replacement column control unit is functioning properly. There is no requirement for a post-repair verification test or a user acknowledgment that the corrective action has been completed and the device is safe for use.","response":"Field Safety Notice 34478/26 issued by BfArM on 2026-08-17 reported that Getinge is implementing a Field Safety Corrective Action to replace the affected column control unit in installed devices for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(8) of Regulation (EU) 2017/745, which requires the field safety notice to clearly indicate all the actions to be taken by users and to explain the reasons for the corrective action without understating the level of risk. The logical failure is the absence of a verification step in the FSCA, leaving users without a clear method to confirm that the risk has been mitigated and the device is safe for continued use."}
+{"instruction":"Review the serious incident reporting timeline for the da Vinci X and Xi Reusable Instruments to ensure compliance with the 10-day reporting requirement for incidents involving unanticipated serious deterioration.","context":"The manufacturer received reports of complete grip cable failure in bipolar energy instruments on 2026-08-10, which led to an inability to close jaws and required alternate intervention for hemostasis. The manufacturer classified this as a serious incident involving unanticipated serious deterioration. The formal report to the BfArM was submitted on 2026-08-25, which is 15 days after the manufacturer became aware of the incident.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that for bipolar energy instruments, complete failure of the grip cable may cause an inability to sufficiently close the jaws for bipolar energy delivery, and if bleeding occurs, it may require alternate means of intervention to regain hemostasis, posing a risk to patient safety for Surgical equipment/ Anaesthesia - surgical equipment. This violates Regulation (EU) 2017/745 Article 87(5), which mandates that in the event of death or an unanticipated serious deterioration in a person's state of health, the report shall be provided not later than 10 days after the manufacturer becomes aware of the serious incident. The procedural failure is the 15-day delay in reporting, which exceeds the statutory 10-day limit for incidents involving serious deterioration, indicating a breakdown in the manufacturer's incident triage and reporting workflow."}
+{"instruction":"Audit the incident classification and reporting process for the da Vinci X and Xi Reusable Instruments regarding partial grip cable failure and tissue injury.","context":"The manufacturer identified cases of partial grip cable fraying leading to unintended tissue interaction and injury. The internal committee debated whether this constituted a 'serious incident' or a 'minor adverse event' due to the variability in injury severity. They decided to wait for a consensus on the severity classification before submitting any report to the BfArM. No report was submitted until 2026-09-01, which was 20 days after the initial awareness of the fraying incidents.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that partial failure (fraying) of the grip cable can lead to unintended interaction between tissue and the frayed cable, which could result in tissue injury requiring intervention such as physical pressure, cauterization, or suturing for Surgical equipment/ Anaesthesia - surgical equipment. This violates Regulation (EU) 2017/745 Article 87(3) and 87(7), which require reporting of serious incidents within 15 days and mandate that if the manufacturer is uncertain about whether an incident is reportable, they shall nevertheless submit a report within the required timeframe. The logical failure is the manufacturer's decision to delay reporting pending a severity consensus, ignoring the regulatory obligation to report when uncertainty exists and the 15-day statutory limit for serious incidents."}
+{"instruction":"Evaluate the manufacturer's reporting of the tungsten cable particulate issue in da Vinci instruments, specifically regarding the classification of the risk and the timeliness of the report.","context":"The manufacturer became aware of cable breakage resulting in tungsten particulate falling into patients on 2026-08-12. The risk assessment concluded that the biocompatibility of tungsten was safe and the procedure delay was minor, classifying the incident as 'low risk' and not a serious incident. The manufacturer did not submit a serious incident report but included the information in a quarterly trend report submitted on 2026-09-30.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that cable breakage or fraying may result in tungsten cable particulate falling into the patient, and while retained material is unlikely to cause adverse biological reactions, particulate retrieval may incur a minor procedure delay for Surgical equipment/ Anaesthesia - surgical equipment. This violates Regulation (EU) 2017/745 Article 87(1)(a) and 87(3), as the introduction of foreign particulate into a patient is generally considered a serious incident unless clearly documented as an expected side-effect in the technical documentation and product information. The technical failure is the manufacturer's failure to document this specific failure mode as an expected side-effect in the technical documentation, thereby making it a reportable serious incident that was incorrectly excluded from immediate reporting and deferred to trend reporting."}
+{"instruction":"Review the risk assessment and field safety corrective action evaluation to ensure that the manufacturer has considered the frequency of use, probability of harm, and severity of harm, as required by EU MDR Article 89.","context":"The risk assessment for the da Vinci instrument failure states that the failure rate is 'higher than anticipated' but does not quantify the probability of harm or the severity of potential patient outcomes. The document does not reference the specific criteria for evaluating field safety corrective actions, such as causality, detectability, or probability of recurrence. There is no record of a formal risk assessment being performed in consultation with the competent authority.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that increased complaints regarding frayed or broken grip cables on da Vinci X, Xi, and dV5 reusable instruments with jaws for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(3) of Regulation (EU) 2017/745, which requires the competent authority to evaluate the risks arising from the reported serious incident and the adequacy of the field safety corrective action, taking into account criteria such as frequency of use, probability of harm, and severity of harm. The logical failure in the QMS is the lack of a quantitative risk assessment that considers the clinical impact of instrument failure, leading to a field safety notice that may not adequately address the severity of the risk or the necessary corrective actions for users."}
+{"instruction":"Assess the manufacturer's process for reporting serious incidents to ensure that the reporting is done immediately after the causal relationship is established and not later than the specified deadlines, as required by EU MDR Article 87.","context":"The QMS document states that for serious incidents involving surgical instruments, the manufacturer will report to the competent authority within 30 days of becoming aware of the incident. The procedure does not distinguish between different types of serious incidents, such as those involving death or serious deterioration in health, which require shorter reporting windows. There is no mention of the requirement to report immediately after the causal relationship is established.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that complete failure of a grip cable results in loss of grip functionality, which can lead to tissue injury or bleeding for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 87(1)(a) and Article 87(3) of Regulation (EU) 2017/745, which mandate the reporting of serious incidents immediately after a causal relationship is established or reasonably possible, and not later than 15 days after awareness. The technical failure in the QMS is the use of a uniform 30-day reporting window for all serious incidents, which fails to account for the severity of the incident and the specific deadlines required for incidents involving potential harm to patients."}
+{"instruction":"Review the Field Safety Corrective Action (FSCA) reporting procedures to ensure compliance with the mandatory pre-notification requirements for urgent device removals.","context":"The Quality Management System (QMS) document states that for urgent field safety corrective actions, the manufacturer may initiate the removal of affected instruments from the market immediately to mitigate risk. The procedure explicitly notes that formal notification to the competent authority is not required until the physical recall is 50% complete. This approach is justified in the document as a measure to expedite patient safety without administrative delays.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that urgent removal of affected instruments for Surgical equipment/ Anaesthesia - surgical equipment. This action violates Article 87(8) of Regulation (EU) 2017/745, which mandates that manufacturers report field safety corrective actions in advance of them being undertaken, except in cases of immediate urgency where the action is taken first. The QMS failure lies in the procedural gap that delays regulatory notification until the recall is partially complete, rather than submitting the report immediately upon the decision to initiate the FSCA, thereby breaching the transparency and timely reporting obligations."}
+{"instruction":"Audit the post-market surveillance procedures regarding the collection and reporting of serious incidents identified during a field safety corrective action.","context":"The standard operating procedure for handling field safety notices instructs customers to identify and quarantine affected products and return them via the standard RMA process. The document states that customers are required to inform the manufacturer of any serious incidents or quality problems concerning the use of the subject devices. However, it does not specify a mandatory timeframe for the manufacturer to evaluate and report these incidents to the competent authority, nor does it define the criteria for determining if an incident is 'serious' under MDR definitions.","response":"Field Safety Notice 00518/25 issued by BfArM on 2026-09-02 reported that customers are instructed to identify and quarantine affected products for Surgical equipment/ Anaesthesia - surgical equipment. This procedural gap violates Article 87(3) and Article 87(5) of Regulation (EU) 2017/745, which require manufacturers to report serious incidents within 15 days, or 10 days in cases of death or serious deterioration, after becoming aware of the incident. The QMS failure is the lack of a defined internal workflow to triage customer-reported incidents and the absence of a strict deadline for submitting these reports to the competent authority, risking non-compliance with statutory reporting timelines."}
+{"instruction":"Audit the Field Safety Notice (FSN) content to ensure it meets the requirements for clear risk communication and user action instructions regarding frayed cables.","context":"The draft Field Safety Notice for the surgical instruments states that 'cables may show signs of wear' and advises users to 'monitor the instruments during use.' The document does not specify any immediate actions such as quarantine or return, nor does it explicitly state the potential for tissue injury or the need for intervention. The risk level is described as 'low' in the internal summary, despite the finding indicating potential for tissue injury requiring cauterization.","response":"Field Safety Notice 10832/26 issued by BfArM on 2026-09-08 reported that frayed cables causing unintended tissue interaction for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(8) of Regulation (EU) 2017/745, which requires the field safety notice to explain the reasons for the corrective action without understating the level of risk and to clearly indicate all actions to be taken by users. The technical failure is the understatement of the risk (describing potential tissue injury as low risk) and the lack of clear, mandatory user actions (such as quarantine), which fails to protect patient safety as required by the regulation."}
+{"instruction":"Evaluate the manufacturer's investigation process to ensure that the risk assessment for complete grip cable failure includes all necessary criteria and cooperation with authorities.","context":"The investigation protocol indicates that the manufacturer will conduct a standalone risk assessment without notifying the competent authority or the notified body until the final report is ready. The document states that the manufacturer will alter the device samples to test the new cable design before informing the authorities of these changes. The risk assessment criteria listed in the document omit the probability of recurrence and the severity of harm to the patient.","response":"Field Safety Notice 10832/26 issued by BfArM on 2026-09-08 reported that complete failure of a grip cable resulting in loss of functionality for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(1) and Article 89(3) of Regulation (EU) 2017/745, which require the manufacturer to cooperate with competent authorities and not alter devices in a way that affects evaluation prior to informing them, and to assess risks using specific criteria including probability of recurrence and severity of harm. The logical failure is the exclusion of mandatory risk assessment criteria and the procedural violation of altering evidence (device samples) before notifying the regulatory bodies, which compromises the integrity of the investigation."}
+{"instruction":"Check the trend reporting and complaint handling procedures to ensure that exceeding the acceptability threshold for grip cable complaints triggers the required field safety corrective action analysis.","context":"The QMS document states that complaints regarding fraying or broken grip cables are logged in the general complaint database and reviewed quarterly. It specifies that no immediate action is required unless a single complaint results in a patient death. The document does not mention the 0.5% complaint rate threshold or any requirement to escalate when this threshold is exceeded for specific instruments.","response":"Field Safety Notice 10832/26 issued by BfArM on 2026-09-08 reported that increased complaints regarding fraying or broken grip cables exceeding the 0.5% threshold for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(1) and Article 89(3) of Regulation (EU) 2017/745, which require the manufacturer to perform necessary investigations and risk assessments following the reporting of serious incidents or field safety corrective actions, taking into account the frequency of use and probability of recurrence. The procedural gap is the failure to recognize the exceedance of the complaint rate threshold as a trigger for immediate investigation and risk assessment, relying instead on a delayed quarterly review that ignores the statistical significance of the complaint cluster."}
+{"instruction":"Assess the reporting of the field safety corrective action for the Intuitive Surgical instruments to ensure it was submitted through the electronic system and included in the public database.","context":"The QMS document states that the field safety corrective action for the grip cable issue was communicated to customers via email and a website update. It does not mention the submission of the report to the competent authority via the electronic system referred to in Article 92. The document notes that the public database entry will be made only if the competent authority requests it, rather than as a mandatory step.","response":"Field Safety Notice 10832/26 issued by BfArM on 2026-09-08 reported that urgent medical device removal and design update for grip cables for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 87(1) and Article 89(8) of Regulation (EU) 2017/745, which require reports to be submitted through the electronic system and the field safety notice to be entered in the electronic system to be accessible to the public. The technical failure is the omission of the mandatory submission to the electronic system, relying instead on direct customer communication, which fails to meet the regulatory requirement for centralized, public accessibility of field safety information."}
+{"instruction":"Review the risk assessment for tungsten cable particulate to ensure it addresses the potential for adhesions and procedure delays as required by the MDR.","context":"The risk assessment document concludes that tungsten particulate is biocompatible and therefore poses no significant risk. It states that the potential for adhesions and filmy scar tissue is 'theoretical' and does not require further investigation or corrective action. The document does not consider the probability of occurrence or the severity of the harm in the context of the specific device failure mode.","response":"Field Safety Notice 10832/26 issued by BfArM on 2026-09-08 reported that cable breakage resulting in tungsten particulate and potential adhesions for Surgical equipment/ Anaesthesia - surgical equipment. This violates Article 89(3) of Regulation (EU) 2017/745, which requires the evaluation of risks taking into account the probability of occurrence of direct or indirect harm and the severity of that harm. The logical failure is the dismissal of the risk based solely on biocompatibility, ignoring the specific clinical consequences (adhesions, scar tissue, procedure delays) and the probability of the failure mode, which results in an inadequate risk assessment."}